SEMA3C and cancer: While some of downregulated genes have been previously described as targets for cancer therapy such as asparaginase (Aspg)85, semaphorins (Sema3c)86, Adenosin A1 receptor (Adora1)87, phosphoenolpyruvate (Pck1)88, their association with immune responses are still largely unexplored.